N-(5-chloro-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3,4-dimethyl-4-[6-(2H-pyrazolo[4,3-b]pyridin-3-ylmethyl)isoquinolin-1-yl]-5H-1,2-oxazole;1-(2,5-dimethylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-(5-ethyl-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-fluoro-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)naphthalen-1-ol;1-(2-methylidenepyrrolidin-1-yl)-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)isoquinolin-6-amine;1-(2-methylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-[5-(trifluoromethyl)naphthalen-2-yl]-1H-indazol-3-amine
C149H118ClF6N39O2 — CID 158853161
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(5-chloro-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3,4-dimethyl-4-[6-(2H-pyrazolo[4,3-b]pyridin-3-ylmethyl)isoquinolin-1-yl]-5H-1,2-oxazole;1-(2,5-dimethylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-(5-ethyl-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-fluoro-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)naphthalen-1-ol;1-(2-methylidenepyrrolidin-1-yl)-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)isoquinolin-6-amine;1-(2-methylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-[5-(trifluoromethyl)naphthalen-2-yl]-1H-indazol-3-amine
N-(5-chloro-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3,4-dimethyl-4-[6-(2H-pyrazolo[4,3-b]pyridin-3-ylmethyl)isoquinolin-1-yl]-5H-1,2-oxazole;1-(2,5-dimethylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-(5-ethyl-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-fluoro-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)naphthalen-1-ol;1-(2-methylidenepyrrolidin-1-yl)-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)isoquinolin-6-amine;1-(2-methylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-[5-(trifluoromethyl)naphthalen-2-yl]-1H-indazol-3-amine (PubChem CID 158853161) has the molecular formula C149H118ClF6N39O2 and a molecular weight of 2636.29 g/mol. Its IUPAC name is N-(5-chloro-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3,4-dimethyl-4-[6-(2H-pyrazolo[4,3-b]pyridin-3-ylmethyl)isoquinolin-1-yl]-5H-1,2-oxazole;1-(2,5-dimethylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-(5-ethyl-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-fluoro-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)naphthalen-1-ol;1-(2-methylidenepyrrolidin-1-yl)-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)isoquinolin-6-amine;1-(2-methylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-[5-(trifluoromethyl)naphthalen-2-yl]-1H-indazol-3-amine.
Molecular Properties
| Compound Name | N-(5-chloro-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3,4-dimethyl-4-[6-(2H-pyrazolo[4,3-b]pyridin-3-ylmethyl)isoquinolin-1-yl]-5H-1,2-oxazole;1-(2,5-dimethylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-(5-ethyl-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-fluoro-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)naphthalen-1-ol;1-(2-methylidenepyrrolidin-1-yl)-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)isoquinolin-6-amine;1-(2-methylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-[5-(trifluoromethyl)naphthalen-2-yl]-1H-indazol-3-amine |
|---|---|
| PubChem CID | 158853161 |
| Molecular Formula | C149H118ClF6N39O2 |
| Molecular Weight | 2636.29 g/mol |
| Exact Mass | 2633.99 |
| IUPAC Name | N-(5-chloro-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;3,4-dimethyl-4-[6-(2H-pyrazolo[4,3-b]pyridin-3-ylmethyl)isoquinolin-1-yl]-5H-1,2-oxazole;1-(2,5-dimethylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-(5-ethyl-8-fluoronaphthalen-2-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-fluoro-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)naphthalen-1-ol;1-(2-methylidenepyrrolidin-1-yl)-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)isoquinolin-6-amine;1-(2-methylpyrazol-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;N-[5-(trifluoromethyl)naphthalen-2-yl]-1H-indazol-3-amine |
| SMILES | C=C1CCCN1c1nccc2cc(NC3=NCc4cccnc43)ccc12.CC1=NOCC1(C)c1nccc2cc(Cc3[nH]nc4cccnc34)ccc12.CCc1ccc(F)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cc1cc(-c2nccc3cc(Nc4n[nH]c5cccnc45)ccc23)n(C)n1.Cn1nccc1-c1nccc2cc(Nc3n[nH]c4cccnc34)ccc12.FC(F)(F)c1cccc2cc(Nc3n[nH]c4ccccc34)ccc12.Fc1ccc(Cl)c2ccc(Nc3n[nH]c4cccnc34)cc12.Oc1ccc(F)c2cc(Nc3n[nH]c4cccnc34)ccc12 |
| InChI | InChI=1S/C21H19N5O.C21H19N5.C20H17N7.C19H15N7.C18H12F3N3.C18H15FN4.C16H10ClFN4.C16H11FN4O/c1-13-21(2,12-27-26-13)20-16-6-5-14(10-15(16)7-9-23-20)11-18-19-17(24-25-18)4-3-8-22-19;1-14-4-3-11-26(14)21-18-7-6-17(12-15(18)8-10-23-21)25-20-19-16(13-24-20)5-2-9-22-19;1-12-10-17(27(2)26-12)18-15-6-5-14(11-13(15)7-9-22-18)23-20-19-16(24-25-20)4-3-8-21-19;1-26-16(7-10-22-26)17-14-5-4-13(11-12(14)6-9-21-17)23-19-18-15(24-25-19)3-2-8-20-18;19-18(20,21)15-6-3-4-11-10-12(8-9-13(11)15)22-17-14-5-1-2-7-16(14)23-24-17;1-2-11-5-8-15(19)14-10-12(6-7-13(11)14)21-18-17-16(22-23-18)4-3-9-20-17;17-12-5-6-13(18)11-8-9(3-4-10(11)12)20-16-15-14(21-22-16)2-1-7-19-15;17-12-5-6-14(22)10-4-3-9(8-11(10)12)19-16-15-13(20-21-16)2-1-7-18-15/h3-10H,11-12H2,1-2H3,(H,24,25);2,5-10,12H,1,3-4,11,13H2,(H,24,25);3-11H,1-2H3,(H2,23,24,25);2-11H,1H3,(H2,23,24,25);1-10H,(H2,22,23,24);3-10H,2H2,1H3,(H2,21,22,23);1-8H,(H2,20,21,22);1-8,22H,(H2,19,20,21) |
| InChIKey | IZSDKRSHPHZHCN-UHFFFAOYSA-N |
| XLogP | 33.87 |
| TPSA | 519.82 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 197 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2636.29 |
| LogP ≤ 5 | 33.87 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158853161 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.